Pancreas

1. Overview

The pancreas is a dual-function gland with both exocrine and endocrine components. In the context of the endocrine system, it plays a central role in glucose homeostasis and metabolic regulation by secreting key hormones such as insulin, glucagon, somatostatin, and pancreatic polypeptide. These hormones regulate blood sugar levels, digestion, appetite, and energy balance. Dysfunction of the endocrine pancreas is associated with serious metabolic disorders, most notably diabetes mellitus.

2. Location

The pancreas is located in the upper abdomen, posterior to the stomach and nestled in the curve of the duodenum. It extends horizontally across the posterior abdominal wall from the duodenum (on the right) to the spleen (on the left). Anatomically, it is divided into four parts: head, neck, body, and tail. The endocrine tissue is dispersed throughout the pancreas but is most concentrated in the tail.

3. Structure

The pancreas has two distinct functional components:

• Exocrine component: Comprises about 98–99% of the gland and produces digestive enzymes (not discussed here).

• Endocrine component: Consists of clusters of hormone-secreting cells known as the islets of Langerhans, which constitute about 1–2% of the pancreatic tissue.

The islets of Langerhans contain several cell types:

• Alpha (α) cells: Secrete glucagon.

• Beta (β) cells: Secrete insulin.

• Delta (δ) cells: Secrete somatostatin.

• PP (F) cells: Secrete pancreatic polypeptide.

• Epsilon (ε) cells: Secrete ghrelin (in small amounts).

These cells are richly vascularized to allow rapid hormone delivery into the bloodstream.

4. Function

The endocrine pancreas plays a critical role in maintaining metabolic homeostasis:

• Insulin: Lowers blood glucose by promoting cellular uptake, glycogenesis, and lipogenesis.

• Glucagon: Raises blood glucose by stimulating glycogenolysis and gluconeogenesis in the liver.

• Somatostatin: Inhibits the secretion of insulin, glucagon, and digestive hormones to modulate overall hormonal balance.

• Pancreatic polypeptide: Regulates pancreatic exocrine secretion and gastrointestinal motility and appetite.

• Ghrelin: Plays a minor role in appetite stimulation and energy balance.

5. Physiological role(s)

The endocrine pancreas supports multiple physiological processes:

• Glucose homeostasis: Maintains blood glucose within a narrow range by balancing insulin and glucagon secretion based on the body’s energy state (fed vs fasting).

• Energy metabolism: Facilitates the storage and mobilization of carbohydrates, fats, and proteins according to metabolic needs.

• Digestive modulation: Hormones like somatostatin and pancreatic polypeptide regulate digestive enzyme release and gut motility.

• Nutrient sensing: Pancreatic islet cells sense circulating nutrients and adjust hormone output accordingly.

• Paracrine signaling: Within the islets, local signaling between cell types fine-tunes hormonal responses.

6. Clinical Significance

Disorders of the endocrine pancreas are common and have major health consequences:

• Type 1 Diabetes Mellitus (T1DM):

  • Caused by autoimmune destruction of pancreatic beta cells, leading to absolute insulin deficiency.

  • Presents in childhood or adolescence with hyperglycemia, polyuria, weight loss, and risk of ketoacidosis.

• Type 2 Diabetes Mellitus (T2DM):

  • Characterized by insulin resistance and relative insulin deficiency.

  • Associated with obesity, metabolic syndrome, and often asymptomatic in early stages.

• Hypoglycemia:

  • May result from excessive insulin production (e.g., insulinoma) or medication overdose in diabetics.

  • Symptoms include sweating, confusion, tremors, and in severe cases, coma.

• Insulinoma:

  • A rare tumor of beta cells that causes episodic hypoglycemia due to unregulated insulin secretion.

  • Diagnosed by fasting blood tests and imaging; treated surgically.

• Glucagonoma:

  • A rare alpha-cell tumor leading to excess glucagon production, hyperglycemia, weight loss, and necrolytic migratory erythema.

• Somatostatinoma:

  • Results in diabetes, steatorrhea, and gallstones due to inhibition of multiple hormones.

• Pancreatic transplantation and islet cell therapy:

  • Being explored as treatments for severe T1DM to restore endogenous insulin production.